nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—CYP2C18—Dapsone—systemic lupus erythematosus	0.0667	0.0876	CbGbCtD
Buprenorphine—UGT1A9—Mycophenolate mofetil—systemic lupus erythematosus	0.0578	0.076	CbGbCtD
Buprenorphine—ABCG2—Leflunomide—systemic lupus erythematosus	0.0421	0.0553	CbGbCtD
Buprenorphine—ABCG2—Mycophenolate mofetil—systemic lupus erythematosus	0.026	0.0342	CbGbCtD
Buprenorphine—CYP2A6—Prednisolone—systemic lupus erythematosus	0.0238	0.0313	CbGbCtD
Buprenorphine—CYP3A7—Dapsone—systemic lupus erythematosus	0.0222	0.0291	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Dapsone—systemic lupus erythematosus	0.0222	0.0291	CbGbCtD
Buprenorphine—ABCG2—Hydrocortisone—systemic lupus erythematosus	0.0209	0.0274	CbGbCtD
Buprenorphine—ABCG2—Cyclosporine—systemic lupus erythematosus	0.0197	0.0259	CbGbCtD
Buprenorphine—CYP1A2—Leflunomide—systemic lupus erythematosus	0.0174	0.0228	CbGbCtD
Buprenorphine—CYP3A5—Dapsone—systemic lupus erythematosus	0.0166	0.0218	CbGbCtD
Buprenorphine—CYP2C8—Dapsone—systemic lupus erythematosus	0.016	0.021	CbGbCtD
Buprenorphine—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0156	0.0206	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Hydrocortisone—systemic lupus erythematosus	0.0154	0.0203	CbGbCtD
Buprenorphine—CYP3A7—Hydrocortisone—systemic lupus erythematosus	0.0154	0.0203	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Cyclosporine—systemic lupus erythematosus	0.0146	0.0191	CbGbCtD
Buprenorphine—CYP3A7—Cyclosporine—systemic lupus erythematosus	0.0146	0.0191	CbGbCtD
Buprenorphine—CYP3A5—Mycophenolate mofetil—systemic lupus erythematosus	0.0144	0.0189	CbGbCtD
Buprenorphine—CYP2A6—Dexamethasone—systemic lupus erythematosus	0.014	0.0184	CbGbCtD
Buprenorphine—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.0139	0.0182	CbGbCtD
Buprenorphine—CYP2C19—Dapsone—systemic lupus erythematosus	0.0134	0.0176	CbGbCtD
Buprenorphine—ABCG2—Dexamethasone—systemic lupus erythematosus	0.013	0.0171	CbGbCtD
Buprenorphine—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0124	0.0163	CbGbCtD
Buprenorphine—CYP3A5—Hydrocortisone—systemic lupus erythematosus	0.0116	0.0152	CbGbCtD
Buprenorphine—CYP2C9—Dapsone—systemic lupus erythematosus	0.0111	0.0146	CbGbCtD
Buprenorphine—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.0111	0.0146	CbGbCtD
Buprenorphine—CYP3A5—Cyclosporine—systemic lupus erythematosus	0.0109	0.0144	CbGbCtD
Buprenorphine—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.0105	0.0138	CbGbCtD
Buprenorphine—ABCG2—Methotrexate—systemic lupus erythematosus	0.0104	0.0137	CbGbCtD
Buprenorphine—CYP3A7—Dexamethasone—systemic lupus erythematosus	0.00959	0.0126	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Dexamethasone—systemic lupus erythematosus	0.00959	0.0126	CbGbCtD
Buprenorphine—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.00938	0.0123	CbGbCtD
Buprenorphine—CYP2C19—Prednisone—systemic lupus erythematosus	0.00929	0.0122	CbGbCtD
Buprenorphine—CYP2C19—Cyclosporine—systemic lupus erythematosus	0.00881	0.0116	CbGbCtD
Buprenorphine—CYP2C9—cardial valve—systemic lupus erythematosus	0.00806	0.185	CbGeAlD
Buprenorphine—ABCB1—Betamethasone—systemic lupus erythematosus	0.00805	0.0106	CbGbCtD
Buprenorphine—ABCB1—Prednisolone—systemic lupus erythematosus	0.00794	0.0104	CbGbCtD
Buprenorphine—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.00753	0.00989	CbGbCtD
Buprenorphine—ABCB1—Prednisone—systemic lupus erythematosus	0.0075	0.00985	CbGbCtD
Buprenorphine—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.00742	0.00975	CbGbCtD
Buprenorphine—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.00733	0.00963	CbGbCtD
Buprenorphine—CYP3A5—Dexamethasone—systemic lupus erythematosus	0.00719	0.00945	CbGbCtD
Buprenorphine—ABCB1—Cyclosporine—systemic lupus erythematosus	0.00711	0.00934	CbGbCtD
Buprenorphine—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.00692	0.00909	CbGbCtD
Buprenorphine—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.0067	0.0088	CbGbCtD
Buprenorphine—CYP3A4—Dapsone—systemic lupus erythematosus	0.00648	0.00852	CbGbCtD
Buprenorphine—CYP2C19—Dexamethasone—systemic lupus erythematosus	0.0058	0.00762	CbGbCtD
Buprenorphine—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00562	0.00739	CbGbCtD
Buprenorphine—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00562	0.00739	CbGbCtD
Buprenorphine—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00482	0.00634	CbGbCtD
Buprenorphine—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00482	0.00634	CbGbCtD
Buprenorphine—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00476	0.00625	CbGbCtD
Buprenorphine—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00468	0.00615	CbGbCtD
Buprenorphine—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00451	0.00593	CbGbCtD
Buprenorphine—CYP3A4—Prednisone—systemic lupus erythematosus	0.00449	0.0059	CbGbCtD
Buprenorphine—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.00441	0.0058	CbGbCtD
Buprenorphine—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00426	0.0056	CbGbCtD
Buprenorphine—ABCB1—Methotrexate—systemic lupus erythematosus	0.00376	0.00494	CbGbCtD
Buprenorphine—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00281	0.00369	CbGbCtD
Buprenorphine—Naloxone—TLR4—systemic lupus erythematosus	0.00255	0.889	CrCbGaD
Buprenorphine—CYP2C19—urine—systemic lupus erythematosus	0.00224	0.0514	CbGeAlD
Buprenorphine—OPRL1—lymphoid tissue—systemic lupus erythematosus	0.00188	0.0431	CbGeAlD
Buprenorphine—CYP1A2—urine—systemic lupus erythematosus	0.00183	0.042	CbGeAlD
Buprenorphine—CYP2C9—urine—systemic lupus erythematosus	0.00174	0.0398	CbGeAlD
Buprenorphine—OPRL1—nervous system—systemic lupus erythematosus	0.00144	0.0329	CbGeAlD
Buprenorphine—UGT1A9—kidney—systemic lupus erythematosus	0.00143	0.0327	CbGeAlD
Buprenorphine—OPRL1—central nervous system—systemic lupus erythematosus	0.00138	0.0317	CbGeAlD
Buprenorphine—CYP3A4—urine—systemic lupus erythematosus	0.00133	0.0304	CbGeAlD
Buprenorphine—CYP2D6—urine—systemic lupus erythematosus	0.00131	0.0299	CbGeAlD
Buprenorphine—CYP2C19—blood plasma—systemic lupus erythematosus	0.00117	0.0268	CbGeAlD
Buprenorphine—CYP3A7-CYP3A51P—nephron tubule—systemic lupus erythematosus	0.00115	0.0263	CbGeAlD
Buprenorphine—OPRD1—kidney—systemic lupus erythematosus	0.00113	0.0259	CbGeAlD
Buprenorphine—CYP2C8—blood plasma—systemic lupus erythematosus	0.00102	0.0234	CbGeAlD
Buprenorphine—CYP3A7-CYP3A51P—cortex of kidney—systemic lupus erythematosus	0.000984	0.0225	CbGeAlD
Buprenorphine—CYP1A2—blood plasma—systemic lupus erythematosus	0.000956	0.0219	CbGeAlD
Buprenorphine—CYP3A5—blood plasma—systemic lupus erythematosus	0.000922	0.0211	CbGeAlD
Buprenorphine—CYP2C9—blood plasma—systemic lupus erythematosus	0.000908	0.0208	CbGeAlD
Buprenorphine—OPRD1—nervous system—systemic lupus erythematosus	0.000741	0.017	CbGeAlD
Buprenorphine—OPRD1—central nervous system—systemic lupus erythematosus	0.000713	0.0163	CbGeAlD
Buprenorphine—OPRK1—nervous system—systemic lupus erythematosus	0.00071	0.0163	CbGeAlD
Buprenorphine—CYP3A4—blood plasma—systemic lupus erythematosus	0.000692	0.0159	CbGeAlD
Buprenorphine—OPRK1—central nervous system—systemic lupus erythematosus	0.000684	0.0157	CbGeAlD
Buprenorphine—CYP2D6—blood plasma—systemic lupus erythematosus	0.000681	0.0156	CbGeAlD
Buprenorphine—CYP2A6—lung—systemic lupus erythematosus	0.000585	0.0134	CbGeAlD
Buprenorphine—ABCG2—nephron tubule—systemic lupus erythematosus	0.000512	0.0117	CbGeAlD
Buprenorphine—OPRM1—nervous system—systemic lupus erythematosus	0.000505	0.0116	CbGeAlD
Buprenorphine—ABCB1—blood plasma—systemic lupus erythematosus	0.00049	0.0112	CbGeAlD
Buprenorphine—OPRM1—central nervous system—systemic lupus erythematosus	0.000486	0.0111	CbGeAlD
Buprenorphine—CYP3A5—nephron tubule—systemic lupus erythematosus	0.000476	0.0109	CbGeAlD
Buprenorphine—CYP2C8—kidney—systemic lupus erythematosus	0.000463	0.0106	CbGeAlD
Buprenorphine—CYP3A5—kidney—systemic lupus erythematosus	0.000418	0.00958	CbGeAlD
Buprenorphine—CYP3A5—cortex of kidney—systemic lupus erythematosus	0.000407	0.00933	CbGeAlD
Buprenorphine—ABCG2—bone marrow—systemic lupus erythematosus	0.000352	0.00807	CbGeAlD
Buprenorphine—ABCG2—lung—systemic lupus erythematosus	0.000319	0.00731	CbGeAlD
Buprenorphine—Naloxone—ALB—systemic lupus erythematosus	0.000318	0.111	CrCbGaD
Buprenorphine—CYP3A4—kidney—systemic lupus erythematosus	0.000314	0.00719	CbGeAlD
Buprenorphine—CYP2D6—kidney—systemic lupus erythematosus	0.000309	0.00707	CbGeAlD
Buprenorphine—CYP1A2—lung—systemic lupus erythematosus	0.000307	0.00704	CbGeAlD
Buprenorphine—CYP3A5—lung—systemic lupus erythematosus	0.000296	0.00679	CbGeAlD
Buprenorphine—ABCB1—nephron tubule—systemic lupus erythematosus	0.000253	0.00579	CbGeAlD
Buprenorphine—ABCB1—kidney—systemic lupus erythematosus	0.000222	0.00509	CbGeAlD
Buprenorphine—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000216	0.00495	CbGeAlD
Buprenorphine—CYP3A4—nervous system—systemic lupus erythematosus	0.000206	0.00472	CbGeAlD
Buprenorphine—CYP2D6—nervous system—systemic lupus erythematosus	0.000203	0.00464	CbGeAlD
Buprenorphine—CYP3A4—central nervous system—systemic lupus erythematosus	0.000198	0.00454	CbGeAlD
Buprenorphine—CYP2D6—central nervous system—systemic lupus erythematosus	0.000195	0.00447	CbGeAlD
Buprenorphine—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000191	0.00437	CbGeAlD
Buprenorphine—ABCB1—bone marrow—systemic lupus erythematosus	0.000174	0.00398	CbGeAlD
Buprenorphine—ABCB1—lung—systemic lupus erythematosus	0.000157	0.0036	CbGeAlD
Buprenorphine—ABCB1—nervous system—systemic lupus erythematosus	0.000146	0.00334	CbGeAlD
Buprenorphine—ABCB1—central nervous system—systemic lupus erythematosus	0.00014	0.00321	CbGeAlD
Buprenorphine—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	9.86e-05	0.000575	CcSEcCtD
Buprenorphine—Fatigue—Hydrocortisone—systemic lupus erythematosus	9.85e-05	0.000574	CcSEcCtD
Buprenorphine—Vision blurred—Prednisone—systemic lupus erythematosus	9.81e-05	0.000572	CcSEcCtD
Buprenorphine—Urethral disorder—Methotrexate—systemic lupus erythematosus	9.8e-05	0.000572	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	9.8e-05	0.000572	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	9.78e-05	0.00057	CcSEcCtD
Buprenorphine—Pain—Hydrocortisone—systemic lupus erythematosus	9.77e-05	0.00057	CcSEcCtD
Buprenorphine—Oedema—Dexamethasone—systemic lupus erythematosus	9.76e-05	0.000569	CcSEcCtD
Buprenorphine—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	9.76e-05	0.000569	CcSEcCtD
Buprenorphine—Oedema—Betamethasone—systemic lupus erythematosus	9.76e-05	0.000569	CcSEcCtD
Buprenorphine—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	9.76e-05	0.000569	CcSEcCtD
Buprenorphine—Insomnia—Triamcinolone—systemic lupus erythematosus	9.73e-05	0.000567	CcSEcCtD
Buprenorphine—Insomnia—Methylprednisolone—systemic lupus erythematosus	9.7e-05	0.000566	CcSEcCtD
Buprenorphine—Infection—Betamethasone—systemic lupus erythematosus	9.69e-05	0.000565	CcSEcCtD
Buprenorphine—Infection—Dexamethasone—systemic lupus erythematosus	9.69e-05	0.000565	CcSEcCtD
Buprenorphine—Ill-defined disorder—Prednisone—systemic lupus erythematosus	9.66e-05	0.000564	CcSEcCtD
Buprenorphine—Paraesthesia—Triamcinolone—systemic lupus erythematosus	9.66e-05	0.000563	CcSEcCtD
Buprenorphine—Feeling abnormal—Prednisolone—systemic lupus erythematosus	9.64e-05	0.000562	CcSEcCtD
Buprenorphine—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	9.63e-05	0.000562	CcSEcCtD
Buprenorphine—Visual impairment—Methotrexate—systemic lupus erythematosus	9.63e-05	0.000562	CcSEcCtD
Buprenorphine—Shock—Dexamethasone—systemic lupus erythematosus	9.6e-05	0.00056	CcSEcCtD
Buprenorphine—Shock—Betamethasone—systemic lupus erythematosus	9.6e-05	0.00056	CcSEcCtD
Buprenorphine—Dyspnoea—Triamcinolone—systemic lupus erythematosus	9.59e-05	0.000559	CcSEcCtD
Buprenorphine—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	9.57e-05	0.000558	CcSEcCtD
Buprenorphine—Nervous system disorder—Betamethasone—systemic lupus erythematosus	9.57e-05	0.000558	CcSEcCtD
Buprenorphine—Agitation—Prednisone—systemic lupus erythematosus	9.57e-05	0.000558	CcSEcCtD
Buprenorphine—Tachycardia—Dexamethasone—systemic lupus erythematosus	9.52e-05	0.000556	CcSEcCtD
Buprenorphine—Tachycardia—Betamethasone—systemic lupus erythematosus	9.52e-05	0.000556	CcSEcCtD
Buprenorphine—Angioedema—Prednisone—systemic lupus erythematosus	9.51e-05	0.000555	CcSEcCtD
Buprenorphine—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	9.47e-05	0.000552	CcSEcCtD
Buprenorphine—Dyspepsia—Triamcinolone—systemic lupus erythematosus	9.47e-05	0.000552	CcSEcCtD
Buprenorphine—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	9.44e-05	0.000551	CcSEcCtD
Buprenorphine—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	9.43e-05	0.00055	CcSEcCtD
Buprenorphine—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	9.43e-05	0.00055	CcSEcCtD
Buprenorphine—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	9.41e-05	0.000549	CcSEcCtD
Buprenorphine—Malaise—Prednisone—systemic lupus erythematosus	9.39e-05	0.000548	CcSEcCtD
Buprenorphine—Vertigo—Prednisone—systemic lupus erythematosus	9.35e-05	0.000546	CcSEcCtD
Buprenorphine—Eye disorder—Methotrexate—systemic lupus erythematosus	9.34e-05	0.000545	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	9.34e-05	0.000545	CcSEcCtD
Buprenorphine—Syncope—Prednisone—systemic lupus erythematosus	9.34e-05	0.000545	CcSEcCtD
Buprenorphine—Tinnitus—Methotrexate—systemic lupus erythematosus	9.32e-05	0.000544	CcSEcCtD
Buprenorphine—Anorexia—Dexamethasone—systemic lupus erythematosus	9.3e-05	0.000543	CcSEcCtD
Buprenorphine—Anorexia—Betamethasone—systemic lupus erythematosus	9.3e-05	0.000543	CcSEcCtD
Buprenorphine—Urticaria—Prednisolone—systemic lupus erythematosus	9.29e-05	0.000542	CcSEcCtD
Buprenorphine—Cardiac disorder—Methotrexate—systemic lupus erythematosus	9.28e-05	0.000541	CcSEcCtD
Buprenorphine—Fatigue—Triamcinolone—systemic lupus erythematosus	9.27e-05	0.000541	CcSEcCtD
Buprenorphine—Fatigue—Methylprednisolone—systemic lupus erythematosus	9.25e-05	0.00054	CcSEcCtD
Buprenorphine—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	9.24e-05	0.000539	CcSEcCtD
Buprenorphine—Asthenia—Cyclosporine—systemic lupus erythematosus	9.22e-05	0.000538	CcSEcCtD
Buprenorphine—Pain—Triamcinolone—systemic lupus erythematosus	9.2e-05	0.000536	CcSEcCtD
Buprenorphine—Loss of consciousness—Prednisone—systemic lupus erythematosus	9.15e-05	0.000534	CcSEcCtD
Buprenorphine—Hypotension—Dexamethasone—systemic lupus erythematosus	9.12e-05	0.000532	CcSEcCtD
Buprenorphine—Hypotension—Betamethasone—systemic lupus erythematosus	9.12e-05	0.000532	CcSEcCtD
Buprenorphine—Pruritus—Cyclosporine—systemic lupus erythematosus	9.09e-05	0.00053	CcSEcCtD
Buprenorphine—Urticaria—Hydrocortisone—systemic lupus erythematosus	9.07e-05	0.000529	CcSEcCtD
Buprenorphine—Angiopathy—Methotrexate—systemic lupus erythematosus	9.07e-05	0.000529	CcSEcCtD
Buprenorphine—Immune system disorder—Methotrexate—systemic lupus erythematosus	9.03e-05	0.000527	CcSEcCtD
Buprenorphine—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	9.03e-05	0.000527	CcSEcCtD
Buprenorphine—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	9.03e-05	0.000527	CcSEcCtD
Buprenorphine—Convulsion—Prednisone—systemic lupus erythematosus	9.02e-05	0.000526	CcSEcCtD
Buprenorphine—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	9.01e-05	0.000526	CcSEcCtD
Buprenorphine—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	8.99e-05	0.000525	CcSEcCtD
Buprenorphine—Hypertension—Prednisone—systemic lupus erythematosus	8.99e-05	0.000524	CcSEcCtD
Buprenorphine—Chills—Methotrexate—systemic lupus erythematosus	8.97e-05	0.000523	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	8.89e-05	0.000519	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	8.89e-05	0.000519	CcSEcCtD
Buprenorphine—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	8.87e-05	0.000517	CcSEcCtD
Buprenorphine—Myalgia—Prednisone—systemic lupus erythematosus	8.86e-05	0.000517	CcSEcCtD
Buprenorphine—Arthralgia—Prednisone—systemic lupus erythematosus	8.86e-05	0.000517	CcSEcCtD
Buprenorphine—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	8.86e-05	0.000517	CcSEcCtD
Buprenorphine—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	8.84e-05	0.000516	CcSEcCtD
Buprenorphine—Anxiety—Prednisone—systemic lupus erythematosus	8.83e-05	0.000515	CcSEcCtD
Buprenorphine—Insomnia—Dexamethasone—systemic lupus erythematosus	8.83e-05	0.000515	CcSEcCtD
Buprenorphine—Insomnia—Betamethasone—systemic lupus erythematosus	8.83e-05	0.000515	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	8.8e-05	0.000514	CcSEcCtD
Buprenorphine—Diarrhoea—Cyclosporine—systemic lupus erythematosus	8.79e-05	0.000513	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	8.77e-05	0.000512	CcSEcCtD
Buprenorphine—Paraesthesia—Dexamethasone—systemic lupus erythematosus	8.76e-05	0.000511	CcSEcCtD
Buprenorphine—Paraesthesia—Betamethasone—systemic lupus erythematosus	8.76e-05	0.000511	CcSEcCtD
Buprenorphine—Discomfort—Prednisone—systemic lupus erythematosus	8.76e-05	0.000511	CcSEcCtD
Buprenorphine—Mental disorder—Methotrexate—systemic lupus erythematosus	8.76e-05	0.000511	CcSEcCtD
Buprenorphine—Malnutrition—Methotrexate—systemic lupus erythematosus	8.7e-05	0.000508	CcSEcCtD
Buprenorphine—Erythema—Methotrexate—systemic lupus erythematosus	8.7e-05	0.000508	CcSEcCtD
Buprenorphine—Hypersensitivity—Prednisolone—systemic lupus erythematosus	8.62e-05	0.000503	CcSEcCtD
Buprenorphine—Dyspepsia—Betamethasone—systemic lupus erythematosus	8.59e-05	0.000501	CcSEcCtD
Buprenorphine—Dyspepsia—Dexamethasone—systemic lupus erythematosus	8.59e-05	0.000501	CcSEcCtD
Buprenorphine—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	8.58e-05	0.0005	CcSEcCtD
Buprenorphine—Urticaria—Triamcinolone—systemic lupus erythematosus	8.54e-05	0.000498	CcSEcCtD
Buprenorphine—Urticaria—Methylprednisolone—systemic lupus erythematosus	8.52e-05	0.000497	CcSEcCtD
Buprenorphine—Dysgeusia—Methotrexate—systemic lupus erythematosus	8.52e-05	0.000497	CcSEcCtD
Buprenorphine—Body temperature increased—Triamcinolone—systemic lupus erythematosus	8.5e-05	0.000496	CcSEcCtD
Buprenorphine—Dizziness—Cyclosporine—systemic lupus erythematosus	8.5e-05	0.000496	CcSEcCtD
Buprenorphine—Anaphylactic shock—Prednisone—systemic lupus erythematosus	8.5e-05	0.000496	CcSEcCtD
Buprenorphine—Oedema—Prednisone—systemic lupus erythematosus	8.5e-05	0.000496	CcSEcCtD
Buprenorphine—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	8.48e-05	0.000495	CcSEcCtD
Buprenorphine—Decreased appetite—Dexamethasone—systemic lupus erythematosus	8.48e-05	0.000495	CcSEcCtD
Buprenorphine—Decreased appetite—Betamethasone—systemic lupus erythematosus	8.48e-05	0.000495	CcSEcCtD
Buprenorphine—Infection—Prednisone—systemic lupus erythematosus	8.44e-05	0.000492	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	8.42e-05	0.000491	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	8.42e-05	0.000491	CcSEcCtD
Buprenorphine—Back pain—Methotrexate—systemic lupus erythematosus	8.42e-05	0.000491	CcSEcCtD
Buprenorphine—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	8.41e-05	0.000491	CcSEcCtD
Buprenorphine—Fatigue—Dexamethasone—systemic lupus erythematosus	8.41e-05	0.000491	CcSEcCtD
Buprenorphine—Fatigue—Betamethasone—systemic lupus erythematosus	8.41e-05	0.000491	CcSEcCtD
Buprenorphine—Shock—Prednisone—systemic lupus erythematosus	8.36e-05	0.000488	CcSEcCtD
Buprenorphine—Pain—Dexamethasone—systemic lupus erythematosus	8.34e-05	0.000487	CcSEcCtD
Buprenorphine—Pain—Betamethasone—systemic lupus erythematosus	8.34e-05	0.000487	CcSEcCtD
Buprenorphine—Nervous system disorder—Prednisone—systemic lupus erythematosus	8.33e-05	0.000486	CcSEcCtD
Buprenorphine—Tachycardia—Prednisone—systemic lupus erythematosus	8.29e-05	0.000484	CcSEcCtD
Buprenorphine—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	8.29e-05	0.000484	CcSEcCtD
Buprenorphine—Skin disorder—Prednisone—systemic lupus erythematosus	8.25e-05	0.000481	CcSEcCtD
Buprenorphine—Hyperhidrosis—Prednisone—systemic lupus erythematosus	8.21e-05	0.000479	CcSEcCtD
Buprenorphine—Vision blurred—Methotrexate—systemic lupus erythematosus	8.2e-05	0.000478	CcSEcCtD
Buprenorphine—Asthenia—Hydrocortisone—systemic lupus erythematosus	8.19e-05	0.000478	CcSEcCtD
Buprenorphine—Vomiting—Cyclosporine—systemic lupus erythematosus	8.17e-05	0.000477	CcSEcCtD
Buprenorphine—Rash—Cyclosporine—systemic lupus erythematosus	8.1e-05	0.000473	CcSEcCtD
Buprenorphine—Anorexia—Prednisone—systemic lupus erythematosus	8.1e-05	0.000473	CcSEcCtD
Buprenorphine—Dermatitis—Cyclosporine—systemic lupus erythematosus	8.1e-05	0.000472	CcSEcCtD
Buprenorphine—Pruritus—Hydrocortisone—systemic lupus erythematosus	8.08e-05	0.000471	CcSEcCtD
Buprenorphine—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	8.07e-05	0.000471	CcSEcCtD
Buprenorphine—Headache—Cyclosporine—systemic lupus erythematosus	8.05e-05	0.00047	CcSEcCtD
Buprenorphine—Feeling abnormal—Betamethasone—systemic lupus erythematosus	8.04e-05	0.000469	CcSEcCtD
Buprenorphine—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	8.04e-05	0.000469	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	7.98e-05	0.000465	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	7.98e-05	0.000465	CcSEcCtD
Buprenorphine—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	7.97e-05	0.000465	CcSEcCtD
Buprenorphine—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	7.92e-05	0.000462	CcSEcCtD
Buprenorphine—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	7.91e-05	0.000461	CcSEcCtD
Buprenorphine—Rash—Mycophenolate mofetil—systemic lupus erythematosus	7.9e-05	0.000461	CcSEcCtD
Buprenorphine—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	7.9e-05	0.000461	CcSEcCtD
Buprenorphine—Headache—Mycophenolate mofetil—systemic lupus erythematosus	7.85e-05	0.000458	CcSEcCtD
Buprenorphine—Malaise—Methotrexate—systemic lupus erythematosus	7.85e-05	0.000458	CcSEcCtD
Buprenorphine—Vertigo—Methotrexate—systemic lupus erythematosus	7.82e-05	0.000456	CcSEcCtD
Buprenorphine—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	7.81e-05	0.000456	CcSEcCtD
Buprenorphine—Urticaria—Dexamethasone—systemic lupus erythematosus	7.75e-05	0.000452	CcSEcCtD
Buprenorphine—Urticaria—Betamethasone—systemic lupus erythematosus	7.75e-05	0.000452	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	7.74e-05	0.000452	CcSEcCtD
Buprenorphine—Dizziness—Prednisolone—systemic lupus erythematosus	7.73e-05	0.000451	CcSEcCtD
Buprenorphine—Asthenia—Triamcinolone—systemic lupus erythematosus	7.72e-05	0.00045	CcSEcCtD
Buprenorphine—Body temperature increased—Betamethasone—systemic lupus erythematosus	7.71e-05	0.00045	CcSEcCtD
Buprenorphine—Abdominal pain—Dexamethasone—systemic lupus erythematosus	7.71e-05	0.00045	CcSEcCtD
Buprenorphine—Abdominal pain—Betamethasone—systemic lupus erythematosus	7.71e-05	0.00045	CcSEcCtD
Buprenorphine—Body temperature increased—Dexamethasone—systemic lupus erythematosus	7.71e-05	0.00045	CcSEcCtD
Buprenorphine—Asthenia—Methylprednisolone—systemic lupus erythematosus	7.7e-05	0.000449	CcSEcCtD
Buprenorphine—Insomnia—Prednisone—systemic lupus erythematosus	7.69e-05	0.000448	CcSEcCtD
Buprenorphine—Nausea—Cyclosporine—systemic lupus erythematosus	7.63e-05	0.000445	CcSEcCtD
Buprenorphine—Paraesthesia—Prednisone—systemic lupus erythematosus	7.63e-05	0.000445	CcSEcCtD
Buprenorphine—Pruritus—Triamcinolone—systemic lupus erythematosus	7.61e-05	0.000444	CcSEcCtD
Buprenorphine—Cough—Methotrexate—systemic lupus erythematosus	7.59e-05	0.000443	CcSEcCtD
Buprenorphine—Pruritus—Methylprednisolone—systemic lupus erythematosus	7.59e-05	0.000443	CcSEcCtD
Buprenorphine—Dizziness—Hydrocortisone—systemic lupus erythematosus	7.55e-05	0.000441	CcSEcCtD
Buprenorphine—Convulsion—Methotrexate—systemic lupus erythematosus	7.54e-05	0.00044	CcSEcCtD
Buprenorphine—Dyspepsia—Prednisone—systemic lupus erythematosus	7.48e-05	0.000436	CcSEcCtD
Buprenorphine—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	7.45e-05	0.000434	CcSEcCtD
Buprenorphine—Arthralgia—Methotrexate—systemic lupus erythematosus	7.41e-05	0.000432	CcSEcCtD
Buprenorphine—Myalgia—Methotrexate—systemic lupus erythematosus	7.41e-05	0.000432	CcSEcCtD
Buprenorphine—Chest pain—Methotrexate—systemic lupus erythematosus	7.41e-05	0.000432	CcSEcCtD
Buprenorphine—Decreased appetite—Prednisone—systemic lupus erythematosus	7.39e-05	0.000431	CcSEcCtD
Buprenorphine—Rash—Prednisolone—systemic lupus erythematosus	7.37e-05	0.00043	CcSEcCtD
Buprenorphine—Dermatitis—Prednisolone—systemic lupus erythematosus	7.37e-05	0.00043	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	7.36e-05	0.000429	CcSEcCtD
Buprenorphine—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	7.34e-05	0.000428	CcSEcCtD
Buprenorphine—Fatigue—Prednisone—systemic lupus erythematosus	7.33e-05	0.000427	CcSEcCtD
Buprenorphine—Headache—Prednisolone—systemic lupus erythematosus	7.33e-05	0.000427	CcSEcCtD
Buprenorphine—Discomfort—Methotrexate—systemic lupus erythematosus	7.32e-05	0.000427	CcSEcCtD
Buprenorphine—Constipation—Prednisone—systemic lupus erythematosus	7.27e-05	0.000424	CcSEcCtD
Buprenorphine—Vomiting—Hydrocortisone—systemic lupus erythematosus	7.26e-05	0.000424	CcSEcCtD
Buprenorphine—Rash—Hydrocortisone—systemic lupus erythematosus	7.2e-05	0.00042	CcSEcCtD
Buprenorphine—Dermatitis—Hydrocortisone—systemic lupus erythematosus	7.19e-05	0.00042	CcSEcCtD
Buprenorphine—Confusional state—Methotrexate—systemic lupus erythematosus	7.16e-05	0.000418	CcSEcCtD
Buprenorphine—Headache—Hydrocortisone—systemic lupus erythematosus	7.15e-05	0.000417	CcSEcCtD
Buprenorphine—Dizziness—Triamcinolone—systemic lupus erythematosus	7.11e-05	0.000415	CcSEcCtD
Buprenorphine—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	7.1e-05	0.000414	CcSEcCtD
Buprenorphine—Dizziness—Methylprednisolone—systemic lupus erythematosus	7.1e-05	0.000414	CcSEcCtD
Buprenorphine—Infection—Methotrexate—systemic lupus erythematosus	7.06e-05	0.000412	CcSEcCtD
Buprenorphine—Feeling abnormal—Prednisone—systemic lupus erythematosus	7e-05	0.000408	CcSEcCtD
Buprenorphine—Asthenia—Dexamethasone—systemic lupus erythematosus	7e-05	0.000408	CcSEcCtD
Buprenorphine—Asthenia—Betamethasone—systemic lupus erythematosus	7e-05	0.000408	CcSEcCtD
Buprenorphine—Nervous system disorder—Methotrexate—systemic lupus erythematosus	6.96e-05	0.000406	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	6.95e-05	0.000405	CcSEcCtD
Buprenorphine—Nausea—Prednisolone—systemic lupus erythematosus	6.95e-05	0.000405	CcSEcCtD
Buprenorphine—Pruritus—Dexamethasone—systemic lupus erythematosus	6.9e-05	0.000403	CcSEcCtD
Buprenorphine—Pruritus—Betamethasone—systemic lupus erythematosus	6.9e-05	0.000403	CcSEcCtD
Buprenorphine—Skin disorder—Methotrexate—systemic lupus erythematosus	6.9e-05	0.000402	CcSEcCtD
Buprenorphine—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	6.87e-05	0.0004	CcSEcCtD
Buprenorphine—Vomiting—Triamcinolone—systemic lupus erythematosus	6.84e-05	0.000399	CcSEcCtD
Buprenorphine—Vomiting—Methylprednisolone—systemic lupus erythematosus	6.82e-05	0.000398	CcSEcCtD
Buprenorphine—Nausea—Hydrocortisone—systemic lupus erythematosus	6.78e-05	0.000396	CcSEcCtD
Buprenorphine—Rash—Triamcinolone—systemic lupus erythematosus	6.78e-05	0.000396	CcSEcCtD
Buprenorphine—Dermatitis—Triamcinolone—systemic lupus erythematosus	6.77e-05	0.000395	CcSEcCtD
Buprenorphine—Anorexia—Methotrexate—systemic lupus erythematosus	6.77e-05	0.000395	CcSEcCtD
Buprenorphine—Rash—Methylprednisolone—systemic lupus erythematosus	6.77e-05	0.000395	CcSEcCtD
Buprenorphine—Dermatitis—Methylprednisolone—systemic lupus erythematosus	6.76e-05	0.000394	CcSEcCtD
Buprenorphine—Urticaria—Prednisone—systemic lupus erythematosus	6.75e-05	0.000394	CcSEcCtD
Buprenorphine—Headache—Triamcinolone—systemic lupus erythematosus	6.74e-05	0.000393	CcSEcCtD
Buprenorphine—Headache—Methylprednisolone—systemic lupus erythematosus	6.72e-05	0.000392	CcSEcCtD
Buprenorphine—Abdominal pain—Prednisone—systemic lupus erythematosus	6.72e-05	0.000392	CcSEcCtD
Buprenorphine—Body temperature increased—Prednisone—systemic lupus erythematosus	6.72e-05	0.000392	CcSEcCtD
Buprenorphine—Diarrhoea—Dexamethasone—systemic lupus erythematosus	6.68e-05	0.000389	CcSEcCtD
Buprenorphine—Diarrhoea—Betamethasone—systemic lupus erythematosus	6.68e-05	0.000389	CcSEcCtD
Buprenorphine—Hypotension—Methotrexate—systemic lupus erythematosus	6.64e-05	0.000387	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	6.47e-05	0.000377	CcSEcCtD
Buprenorphine—Dizziness—Betamethasone—systemic lupus erythematosus	6.45e-05	0.000376	CcSEcCtD
Buprenorphine—Dizziness—Dexamethasone—systemic lupus erythematosus	6.45e-05	0.000376	CcSEcCtD
Buprenorphine—Insomnia—Methotrexate—systemic lupus erythematosus	6.42e-05	0.000375	CcSEcCtD
Buprenorphine—Nausea—Triamcinolone—systemic lupus erythematosus	6.39e-05	0.000373	CcSEcCtD
Buprenorphine—Paraesthesia—Methotrexate—systemic lupus erythematosus	6.38e-05	0.000372	CcSEcCtD
Buprenorphine—Nausea—Methylprednisolone—systemic lupus erythematosus	6.37e-05	0.000372	CcSEcCtD
Buprenorphine—Dyspnoea—Methotrexate—systemic lupus erythematosus	6.33e-05	0.000369	CcSEcCtD
Buprenorphine—Somnolence—Methotrexate—systemic lupus erythematosus	6.31e-05	0.000368	CcSEcCtD
Buprenorphine—Hypersensitivity—Prednisone—systemic lupus erythematosus	6.26e-05	0.000365	CcSEcCtD
Buprenorphine—Dyspepsia—Methotrexate—systemic lupus erythematosus	6.25e-05	0.000365	CcSEcCtD
Buprenorphine—Vomiting—Dexamethasone—systemic lupus erythematosus	6.2e-05	0.000362	CcSEcCtD
Buprenorphine—Vomiting—Betamethasone—systemic lupus erythematosus	6.2e-05	0.000362	CcSEcCtD
Buprenorphine—Decreased appetite—Methotrexate—systemic lupus erythematosus	6.17e-05	0.00036	CcSEcCtD
Buprenorphine—Rash—Betamethasone—systemic lupus erythematosus	6.15e-05	0.000359	CcSEcCtD
Buprenorphine—Rash—Dexamethasone—systemic lupus erythematosus	6.15e-05	0.000359	CcSEcCtD
Buprenorphine—Dermatitis—Dexamethasone—systemic lupus erythematosus	6.15e-05	0.000359	CcSEcCtD
Buprenorphine—Dermatitis—Betamethasone—systemic lupus erythematosus	6.15e-05	0.000359	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	6.13e-05	0.000358	CcSEcCtD
Buprenorphine—Fatigue—Methotrexate—systemic lupus erythematosus	6.12e-05	0.000357	CcSEcCtD
Buprenorphine—Headache—Dexamethasone—systemic lupus erythematosus	6.11e-05	0.000357	CcSEcCtD
Buprenorphine—Headache—Betamethasone—systemic lupus erythematosus	6.11e-05	0.000357	CcSEcCtD
Buprenorphine—Asthenia—Prednisone—systemic lupus erythematosus	6.1e-05	0.000356	CcSEcCtD
Buprenorphine—Pain—Methotrexate—systemic lupus erythematosus	6.07e-05	0.000354	CcSEcCtD
Buprenorphine—Pruritus—Prednisone—systemic lupus erythematosus	6.01e-05	0.000351	CcSEcCtD
Buprenorphine—Feeling abnormal—Methotrexate—systemic lupus erythematosus	5.85e-05	0.000341	CcSEcCtD
Buprenorphine—Diarrhoea—Prednisone—systemic lupus erythematosus	5.81e-05	0.000339	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	5.81e-05	0.000339	CcSEcCtD
Buprenorphine—Nausea—Dexamethasone—systemic lupus erythematosus	5.8e-05	0.000338	CcSEcCtD
Buprenorphine—Nausea—Betamethasone—systemic lupus erythematosus	5.8e-05	0.000338	CcSEcCtD
Buprenorphine—Urticaria—Methotrexate—systemic lupus erythematosus	5.64e-05	0.000329	CcSEcCtD
Buprenorphine—Dizziness—Prednisone—systemic lupus erythematosus	5.62e-05	0.000328	CcSEcCtD
Buprenorphine—Body temperature increased—Methotrexate—systemic lupus erythematosus	5.61e-05	0.000327	CcSEcCtD
Buprenorphine—Abdominal pain—Methotrexate—systemic lupus erythematosus	5.61e-05	0.000327	CcSEcCtD
Buprenorphine—Vomiting—Prednisone—systemic lupus erythematosus	5.4e-05	0.000315	CcSEcCtD
Buprenorphine—Rash—Prednisone—systemic lupus erythematosus	5.36e-05	0.000313	CcSEcCtD
Buprenorphine—Dermatitis—Prednisone—systemic lupus erythematosus	5.35e-05	0.000312	CcSEcCtD
Buprenorphine—Headache—Prednisone—systemic lupus erythematosus	5.32e-05	0.000311	CcSEcCtD
Buprenorphine—Hypersensitivity—Methotrexate—systemic lupus erythematosus	5.23e-05	0.000305	CcSEcCtD
Buprenorphine—Asthenia—Methotrexate—systemic lupus erythematosus	5.1e-05	0.000297	CcSEcCtD
Buprenorphine—Nausea—Prednisone—systemic lupus erythematosus	5.05e-05	0.000294	CcSEcCtD
Buprenorphine—Pruritus—Methotrexate—systemic lupus erythematosus	5.02e-05	0.000293	CcSEcCtD
Buprenorphine—Diarrhoea—Methotrexate—systemic lupus erythematosus	4.86e-05	0.000283	CcSEcCtD
Buprenorphine—Dizziness—Methotrexate—systemic lupus erythematosus	4.7e-05	0.000274	CcSEcCtD
Buprenorphine—Vomiting—Methotrexate—systemic lupus erythematosus	4.52e-05	0.000263	CcSEcCtD
Buprenorphine—Rash—Methotrexate—systemic lupus erythematosus	4.48e-05	0.000261	CcSEcCtD
Buprenorphine—Dermatitis—Methotrexate—systemic lupus erythematosus	4.47e-05	0.000261	CcSEcCtD
Buprenorphine—Headache—Methotrexate—systemic lupus erythematosus	4.45e-05	0.00026	CcSEcCtD
Buprenorphine—Nausea—Methotrexate—systemic lupus erythematosus	4.22e-05	0.000246	CcSEcCtD
Buprenorphine—OPRD1—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.28e-05	0.00061	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CSK—systemic lupus erythematosus	1.26e-05	0.0006	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—JAK1—systemic lupus erythematosus	1.24e-05	0.000591	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—NAT2—systemic lupus erythematosus	1.24e-05	0.00059	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	1.23e-05	0.000585	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—NAT2—systemic lupus erythematosus	1.23e-05	0.000585	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—CCR5—systemic lupus erythematosus	1.22e-05	0.00058	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	1.2e-05	0.000572	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TLR9—systemic lupus erythematosus	1.2e-05	0.000569	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—C3—systemic lupus erythematosus	1.19e-05	0.000567	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—CCR5—systemic lupus erythematosus	1.18e-05	0.00056	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TYK2—systemic lupus erythematosus	1.17e-05	0.000558	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.16e-05	0.000553	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	1.16e-05	0.000552	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—P2RY12—systemic lupus erythematosus	1.16e-05	0.000551	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NCF2—systemic lupus erythematosus	1.15e-05	0.000549	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—F2—systemic lupus erythematosus	1.15e-05	0.000548	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—C3—systemic lupus erythematosus	1.15e-05	0.000548	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—NOS3—systemic lupus erythematosus	1.15e-05	0.000547	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—LYN—systemic lupus erythematosus	1.15e-05	0.000545	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—JAK1—systemic lupus erythematosus	1.13e-05	0.000537	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—NAT2—systemic lupus erythematosus	1.13e-05	0.000536	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.12e-05	0.000535	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	1.09e-05	0.00052	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—CCR5—systemic lupus erythematosus	1.07e-05	0.000509	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CSK—systemic lupus erythematosus	1.07e-05	0.000507	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	1.05e-05	0.000502	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.05e-05	0.0005	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—JAK1—systemic lupus erythematosus	1.05e-05	0.0005	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—F2—systemic lupus erythematosus	1.05e-05	0.000498	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—C3—systemic lupus erythematosus	1.05e-05	0.000497	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.05e-05	0.000497	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—RXRA—systemic lupus erythematosus	1.04e-05	0.000493	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—JUNB—systemic lupus erythematosus	1.03e-05	0.000491	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—F2—systemic lupus erythematosus	1.01e-05	0.000481	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	1e-05	0.000478	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	9.97e-06	0.000474	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—CCR5—systemic lupus erythematosus	9.96e-06	0.000474	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	9.81e-06	0.000467	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	9.81e-06	0.000467	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—IL2—systemic lupus erythematosus	9.76e-06	0.000464	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NCF2—systemic lupus erythematosus	9.75e-06	0.000464	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—C3—systemic lupus erythematosus	9.73e-06	0.000463	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—IL6—systemic lupus erythematosus	9.71e-06	0.000462	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	9.69e-06	0.000461	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—LYN—systemic lupus erythematosus	9.68e-06	0.000461	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—JAK1—systemic lupus erythematosus	9.54e-06	0.000454	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	9.51e-06	0.000453	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—PRL—systemic lupus erythematosus	9.51e-06	0.000452	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—SH2B3—systemic lupus erythematosus	9.5e-06	0.000452	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—CCL2—systemic lupus erythematosus	9.33e-06	0.000444	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—MMP9—systemic lupus erythematosus	9.23e-06	0.000439	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CXCL12—systemic lupus erythematosus	9.22e-06	0.000439	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	9.2e-06	0.000438	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—F2—systemic lupus erythematosus	9.18e-06	0.000437	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	9.14e-06	0.000435	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—JUNB—systemic lupus erythematosus	9.05e-06	0.000431	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CCR5—systemic lupus erythematosus	9.04e-06	0.00043	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	8.91e-06	0.000424	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—NAT2—systemic lupus erythematosus	8.89e-06	0.000423	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—C3—systemic lupus erythematosus	8.84e-06	0.00042	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	8.78e-06	0.000418	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—EP300—systemic lupus erythematosus	8.75e-06	0.000416	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	8.65e-06	0.000412	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	8.6e-06	0.000409	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—F2—systemic lupus erythematosus	8.54e-06	0.000406	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—TYK2—systemic lupus erythematosus	8.47e-06	0.000403	CbGpPWpGaD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	8.43e-06	0.000401	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	8.35e-06	0.000397	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—PRL—systemic lupus erythematosus	8.34e-06	0.000397	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—VEGFA—systemic lupus erythematosus	8.29e-06	0.000394	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—RXRA—systemic lupus erythematosus	8.2e-06	0.00039	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—CCL2—systemic lupus erythematosus	8.18e-06	0.000389	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	8.03e-06	0.000382	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	7.91e-06	0.000376	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	7.89e-06	0.000375	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CXCL12—systemic lupus erythematosus	7.79e-06	0.000371	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—IL2—systemic lupus erythematosus	7.76e-06	0.000369	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—F2—systemic lupus erythematosus	7.76e-06	0.000369	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—NAT2—systemic lupus erythematosus	7.7e-06	0.000366	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—JUNB—systemic lupus erythematosus	7.65e-06	0.000364	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TGFB1—systemic lupus erythematosus	7.61e-06	0.000362	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—JAK1—systemic lupus erythematosus	7.61e-06	0.000362	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.61e-06	0.000362	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—TYK2—systemic lupus erythematosus	7.43e-06	0.000353	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	7.27e-06	0.000346	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	7.26e-06	0.000345	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CCR5—systemic lupus erythematosus	7.21e-06	0.000343	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL2RA—systemic lupus erythematosus	7.1e-06	0.000338	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL2—systemic lupus erythematosus	7.05e-06	0.000335	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PRL—systemic lupus erythematosus	7.05e-06	0.000335	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—C3—systemic lupus erythematosus	7.04e-06	0.000335	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—RXRA—systemic lupus erythematosus	6.96e-06	0.000331	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CCL2—systemic lupus erythematosus	6.91e-06	0.000329	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—RXRA—systemic lupus erythematosus	6.9e-06	0.000328	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—NAT2—systemic lupus erythematosus	6.87e-06	0.000327	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—IL2—systemic lupus erythematosus	6.81e-06	0.000324	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	6.78e-06	0.000323	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	6.74e-06	0.000321	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	6.71e-06	0.000319	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—JAK1—systemic lupus erythematosus	6.67e-06	0.000317	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PPARG—systemic lupus erythematosus	6.55e-06	0.000311	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	6.32e-06	0.000301	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—RXRA—systemic lupus erythematosus	6.32e-06	0.000301	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CCR5—systemic lupus erythematosus	6.32e-06	0.000301	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—TYK2—systemic lupus erythematosus	6.28e-06	0.000299	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	6.27e-06	0.000298	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL2RA—systemic lupus erythematosus	6.23e-06	0.000296	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—F2—systemic lupus erythematosus	6.18e-06	0.000294	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL2—systemic lupus erythematosus	6.18e-06	0.000294	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—C3—systemic lupus erythematosus	6.18e-06	0.000294	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	6.12e-06	0.000291	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CD80—systemic lupus erythematosus	5.93e-06	0.000282	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—ALB—systemic lupus erythematosus	5.89e-06	0.00028	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—IL2—systemic lupus erythematosus	5.75e-06	0.000274	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—IL6—systemic lupus erythematosus	5.73e-06	0.000273	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—JAK1—systemic lupus erythematosus	5.64e-06	0.000268	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—NOS3—systemic lupus erythematosus	5.63e-06	0.000268	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CCL2—systemic lupus erythematosus	5.51e-06	0.000262	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.5e-06	0.000262	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.46e-06	0.00026	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—F2—systemic lupus erythematosus	5.42e-06	0.000258	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—NAT2—systemic lupus erythematosus	5.36e-06	0.000255	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCR5—systemic lupus erythematosus	5.34e-06	0.000254	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.26e-06	0.00025	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL2—systemic lupus erythematosus	5.22e-06	0.000248	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—C3—systemic lupus erythematosus	5.22e-06	0.000248	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CD80—systemic lupus erythematosus	5.2e-06	0.000247	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PPARG—systemic lupus erythematosus	5.18e-06	0.000246	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PTGS2—systemic lupus erythematosus	5.15e-06	0.000245	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TYK2—systemic lupus erythematosus	5e-06	0.000238	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—RXRA—systemic lupus erythematosus	4.98e-06	0.000237	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.98e-06	0.000237	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—NOS3—systemic lupus erythematosus	4.91e-06	0.000234	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.91e-06	0.000234	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CCL2—systemic lupus erythematosus	4.83e-06	0.00023	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.81e-06	0.000229	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—ALB—systemic lupus erythematosus	4.65e-06	0.000221	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—F2—systemic lupus erythematosus	4.58e-06	0.000218	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	4.56e-06	0.000217	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.48e-06	0.000213	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—NOS3—systemic lupus erythematosus	4.45e-06	0.000212	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CD80—systemic lupus erythematosus	4.39e-06	0.000209	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PPARG—systemic lupus erythematosus	4.39e-06	0.000209	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TYK2—systemic lupus erythematosus	4.39e-06	0.000209	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PPARG—systemic lupus erythematosus	4.35e-06	0.000207	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	4.32e-06	0.000205	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NOS3—systemic lupus erythematosus	4.31e-06	0.000205	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.3e-06	0.000204	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—EP300—systemic lupus erythematosus	4.28e-06	0.000204	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.26e-06	0.000202	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.26e-06	0.000202	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL2—systemic lupus erythematosus	4.16e-06	0.000198	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL6—systemic lupus erythematosus	4.14e-06	0.000197	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	4.13e-06	0.000197	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCL2—systemic lupus erythematosus	4.08e-06	0.000194	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PTGS2—systemic lupus erythematosus	4.07e-06	0.000194	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4e-06	0.00019	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PPARG—systemic lupus erythematosus	3.99e-06	0.00019	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—ALB—systemic lupus erythematosus	3.95e-06	0.000188	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—MMP9—systemic lupus erythematosus	3.94e-06	0.000187	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.93e-06	0.000187	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.92e-06	0.000186	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—ALB—systemic lupus erythematosus	3.91e-06	0.000186	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—RXRA—systemic lupus erythematosus	3.85e-06	0.000183	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.83e-06	0.000182	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—NOS3—systemic lupus erythematosus	3.78e-06	0.00018	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	3.76e-06	0.000179	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—NOS3—systemic lupus erythematosus	3.74e-06	0.000178	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—EP300—systemic lupus erythematosus	3.74e-06	0.000178	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.73e-06	0.000177	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TYK2—systemic lupus erythematosus	3.71e-06	0.000176	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL2—systemic lupus erythematosus	3.65e-06	0.000174	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NOS3—systemic lupus erythematosus	3.64e-06	0.000173	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL6—systemic lupus erythematosus	3.63e-06	0.000173	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—ALB—systemic lupus erythematosus	3.59e-06	0.000171	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.57e-06	0.00017	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	3.54e-06	0.000169	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.54e-06	0.000168	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	3.51e-06	0.000167	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MMP9—systemic lupus erythematosus	3.46e-06	0.000164	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PTGS2—systemic lupus erythematosus	3.46e-06	0.000164	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.44e-06	0.000164	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—NOS3—systemic lupus erythematosus	3.43e-06	0.000163	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PTGS2—systemic lupus erythematosus	3.42e-06	0.000163	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—EP300—systemic lupus erythematosus	3.39e-06	0.000161	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.35e-06	0.000159	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—EP300—systemic lupus erythematosus	3.28e-06	0.000156	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.26e-06	0.000155	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.25e-06	0.000155	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.15e-06	0.00015	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PPARG—systemic lupus erythematosus	3.15e-06	0.00015	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PTGS2—systemic lupus erythematosus	3.14e-06	0.000149	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.1e-06	0.000148	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL2—systemic lupus erythematosus	3.09e-06	0.000147	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL6—systemic lupus erythematosus	3.07e-06	0.000146	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	3e-06	0.000143	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MMP9—systemic lupus erythematosus	2.92e-06	0.000139	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.91e-06	0.000138	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—EP300—systemic lupus erythematosus	2.87e-06	0.000137	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—EP300—systemic lupus erythematosus	2.85e-06	0.000135	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.85e-06	0.000135	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ALB—systemic lupus erythematosus	2.83e-06	0.000135	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.79e-06	0.000132	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—EP300—systemic lupus erythematosus	2.77e-06	0.000132	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	2.73e-06	0.00013	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—NOS3—systemic lupus erythematosus	2.71e-06	0.000129	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.62e-06	0.000125	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—EP300—systemic lupus erythematosus	2.61e-06	0.000124	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PTGS2—systemic lupus erythematosus	2.48e-06	0.000118	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	2.45e-06	0.000117	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL6—systemic lupus erythematosus	2.45e-06	0.000116	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PPARG—systemic lupus erythematosus	2.43e-06	0.000116	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.41e-06	0.000115	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	2.37e-06	0.000113	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	2.34e-06	0.000112	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	2.32e-06	0.00011	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	2.24e-06	0.000106	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	2.22e-06	0.000106	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ALB—systemic lupus erythematosus	2.19e-06	0.000104	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL6—systemic lupus erythematosus	2.15e-06	0.000102	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	2.14e-06	0.000102	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ALB—systemic lupus erythematosus	2.14e-06	0.000102	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—NOS3—systemic lupus erythematosus	2.09e-06	9.95e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—EP300—systemic lupus erythematosus	2.06e-06	9.79e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	2.04e-06	9.72e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	2.01e-06	9.57e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	1.99e-06	9.49e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	1.92e-06	9.15e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PTGS2—systemic lupus erythematosus	1.91e-06	9.1e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	1.91e-06	9.08e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	1.9e-06	9.02e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	1.87e-06	8.89e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL6—systemic lupus erythematosus	1.81e-06	8.63e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	1.78e-06	8.48e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	1.76e-06	8.37e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	1.75e-06	8.3e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	1.7e-06	8.11e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	1.63e-06	7.76e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—EP300—systemic lupus erythematosus	1.59e-06	7.57e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—EP300—systemic lupus erythematosus	1.55e-06	7.39e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	1.49e-06	7.09e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	1.46e-06	6.96e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	1.46e-06	6.96e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	1.45e-06	6.9e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	1.32e-06	6.26e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	1.26e-06	5.99e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	1.24e-06	5.9e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	1.15e-06	5.47e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	9.57e-07	4.55e-05	CbGpPWpGaD
